Annovis Bio, Inc. Share Price
NYSE: ANVS | Micro CapAnnovis Bio, Inc. Stock Performance
Annovis Bio, Inc. Share Price Today
As of 29 October 2026, Annovis Bio, Inc.'s share price is $1.03. The stock opened at $1.01, compared to its previous close of $1.02. During today's trading session, Annovis Bio, Inc.'s share price traded between $1.01 and $1.03, with an average price of $1.02. Over the past 52 weeks, the stock has recorded a high of $5.50 and a low of $0.94. In terms of performance, Annovis Bio, Inc.'s share price has declined by 47.72% over the last six months and is down 50.72% on a year-on-year basis.
Annovis Bio, Inc. Share Price Chart
Annovis Bio, Inc. Quarterly Profit & Loss
All figures in USD
Annovis Bio, Inc. Annual Profit & Loss
All figures in USD
About Annovis Bio, Inc.
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.
Annovis Bio, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.26 | $1.01 | -20.78% |
Sep 2026 | $1.69 | $1.28 | -28.89% |
Aug 2026 | $1.75 | $1.80 | +2.86% |
Jul 2026 | $1.89 | $1.75 | -5.66% |
Jun 2026 | $1.96 | $1.85 | -3.39% |
May 2026 | $1.98 | $1.92 | -2.54% |
Apr 2026 | $2.26 | $1.97 | -11.26% |
Mar 2026 | $2.56 | $2.22 | -17.16% |
Feb 2026 | $2.70 | $2.68 | +0.00% |
Jan 2026 | $3.40 | $2.68 | -21.64% |
Dec 2025 | $5.09 | $3.42 | -32.94% |
Nov 2025 | $2.03 | $5.10 | +144.02% |